FDA Warns Court Not To Side With Sandoz In Drug Challenge

By Piper Hudspeth Blackburn · November 7, 2022, 9:56 PM EST

The U.S. Food and Drug Administration warned the D.C. Circuit on Monday that the court risked upending the way the agency awards exclusivity to drugs and provides incentives to create new ones...

To view the full article, register now.

Case Information

Case Title

Sandoz Inc. v. Xavier Becerra, et al

Case Number

22-5202

Court

Appellate - DC Circuit

Nature of Suit

2899 Other Statutes APA/Review Agency

Date Filed

July 27, 2022